Our results support thecurrent evidence for use of GnRH antagonists and addition of metformin to GnRH agonist to decrease OHSS (1).There is lack of data on use of IVM in PCOS (1), whichis reported by one of included reviews (17). The gene discussed is GNRH1; the disease is polycystic ovary syndrome.